New York, June 16, 2016 -- Moody's Investors Service, ("Moody's") placed the ratings of AmSurg Corporation ("AmSurg") under review for downgrade, including the company's B1 Corporate Family Rating and B1-PD Probability of Default Rating. The rating action follows the announcement on June 15, 2016, that AmSurg entered into a definitive all-stock merger agreement with Envision Healthcare Holdings, Inc. The transaction will create a combined organization with an estimated $8.5 billion in revenues. Envision shareholders will own about 53% of the new entity -- to be name Envision Healthcare Corporation -- and AmSurg shareholders will own 47% of the combined organization. Envision is a leading provider of emergency medical services in the U.S., providing emergency department and hospital physician outsourcing and medical transport.

Vollständigen Artikel bei Moodys lesen